Wikidata

(Q57908992)

English

Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)

article

In more languages

Statements

title
Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS) (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
21670455
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21670455%20AND%20SRC:MED&resulttype=core&format=json
retrieved
4 February 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q57908992&oldid=1998203129"